Absence of peliosis hepatis in patients receiving testosterone enanthate

Fifty-two autopsies of patients who had undergone hemodialysis and had received testosterone enanthate, were reviewed for evidence of peliosis hepatis and liver neoplasms. Eight (15%) pathologic liver were isolated. No peliosis, adenoma or hepatoma was identified. These findings suggest that, unlike the 17-alpha derivatives of testosterone, testosterone enanthate is not associated with morphologic changes in the liver.